Contribute Information
Can you contribute information about this project?
Contact the EWS Team
According to the Bank’s website, ISA Lab is a tech enabled healthcare services company in Brazil. It offers homecare medical services such as vaccination, testing, infusion, clinical visits, and chronic disease management at the patient’s home. ISA operates a B2B (business-to-business)/B2B2C (business-to-business-to-consumer) model connecting individual medical professionals (“ISAs”) to patients. It has a decentralized model and a network of independent healthcare professionals currently operating in 65 cities across Brazil. ISA does not operate any healthcare facilities and services are limited to home visits where healthcare professionals go directly to the patient's residence to provide medical care and support.
This is a category B project according to IFC’s Policy on Environmental and Social Sustainability. Key E&S issues and risks associated with the project are expected to include: (i) company’s capacity to implement an environment, health, safety, and social management system (ESMS) in line with IFC Performance Standards (PS), World Bank Group’s General Environmental Health and Safety (EHS) Guidelines and EHS Guidelines for Health Care Facilities, (ii) resource efficiency and pollution prevention and management, including water, waste and hazardous waste management; (iii) occupational health and safety; management of labor and working conditions including direct and indirect employees management; (iv) Gender-based Violence (GBV) risks in the workplace and patients homes; (v) stakeholder engagement and community health, safety, and security, and (vi) Life and Fire Safety (LFS) risks.
An investment of US$15 million in ISA in the form of direct equity.
ISA Lab was founded by Fernando and David Pares. Notable existing shareholders include Canary, Vox Capital, MatterScale, Kortex Ventures, Yaya and Scale-Up Ventures.
| Private Actor 1 | Private Actor 1 Role | Private Actor 1 Sector | Relation | Private Actor 2 | Private Actor 2 Role | Private Actor 2 Sector |
|---|---|---|---|---|---|---|
| - | - | - | - | ISA Lab | Client | - |
ISA Lab
Fernando Pares
CEO
+55 (11) 2199-4725
contato@isasaude.com
Alameda Santos 2400, Sao Paulo, Brazil
https://isasaude.com/
ACCESS TO INFORMATION
You can submit a request for information disclosure at: https://disclosures.ifc.org/#/inquiries
If you believe that your request for information from IFC has been unreasonably denied, or that this Policy has been interpreted incorrectly, you can submit a complaint at the link above to IFC's Access to Information Policy Advisor, who reports directly to IFC's Executive Vice President.
ACCOUNTABILITY MECHANISM OF IFC/MIGA
The Compliance Advisor Ombudsman (CAO) is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an IFC or MIGA- financed project. If you submit a complaint to the CAO, they may assist you in resolving a dispute with the company and/or investigate to assess whether the IFC is following its own policies and procedures for preventing harm to people or the environment. If you want to submit a complaint electronically, you can email the CAO at CAO@worldbankgroup.org You can learn more about the CAO and how to file a complaint at http://www.cao-ombudsman.org